Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is PITAVASTATIN CALCIUM, with a corresponding US DMF Number 27144.
Remarkably, this DMF maintains an Active status since its submission on June 25, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 19, 2013, and payment made on June 18, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II